Blaine Davis is Chief Financial Officer of SELECTA BIOSCIENCES INC. Currently has a direct ownership of 94,811 shares of SELB, which is worth approximately $79,641. The most recent transaction as insider was on Jan 06, 2025, when has been sold 4,028 shares (Common Stock) at a price of $16.83 per share, resulting in proceeds of $67,791. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.8K
96.09% 3M change
96.09% 12M change
Total Value Held $79,641

Blaine Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
SELL
Open market or private sale
$67,791 $16.83 p/Share
4,028 Reduced 4.08%
94,811 Common Stock
Jan 03 2025
SELL
Open market or private sale
$66,227 $16.72 p/Share
3,961 Reduced 3.85%
98,839 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
22,000 Added 17.63%
102,800 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
2,424,000 Added 50.0%
2,424,000 Common Stock

Also insider at

TARA
Protara Therapeutics, Inc. Healthcare
BD

Blaine Davis

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on SELB

Follow SELECTA BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SELB shares.

Notify only if

Insider Trading

Get notified when an Selecta Biosciences Inc insider buys or sells SELB shares.

Notify only if

News

Receive news related to SELECTA BIOSCIENCES INC

Track Activities on SELB